The Human Paraoxonase Gene Cluster As a Target in the Treatment of Atherosclerosis
- 15 March 2012
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 16 (6), 597-632
- https://doi.org/10.1089/ars.2010.3774
Abstract
The paraoxonase (PON) gene cluster contains three adjacent gene members, PON1, PON2, and PON3. Originating from the same fungus lactonase precursor, all of the three PON genes share high sequence identity and a similar β propeller protein structure. PON1 and PON3 are primarily expressed in the liver and secreted into the serum upon expression, whereas PON2 is ubiquitously expressed and remains inside the cell. Each PON member has high catalytic activity toward corresponding artificial organophosphate, and all exhibit activities to lactones. Therefore, all three members of the family are regarded as lactonases. Under physiological conditions, they act to degrade metabolites of polyunsaturated fatty acids and homocysteine (Hcy) thiolactone, among other compounds. By detoxifying both oxidized low-density lipoprotein and Hcy thiolactone, PONs protect against atherosclerosis and coronary artery diseases, as has been illustrated by many types of in vitro and in vivo experimental evidence. Clinical observations focusing on gene polymorphisms also indicate that PON1, PON2, and PON3 are protective against coronary artery disease. Many other conditions, such as diabetes, metabolic syndrome, and aging, have been shown to relate to PONs. The abundance and/or activity of PONs can be regulated by lipoproteins and their metabolites, biological macromolecules, pharmacological treatments, dietary factors, and lifestyle. In conclusion, both previous results and ongoing studies provide evidence, making the PON cluster a prospective target for the treatment of atherosclerosis. Antioxid. Redox Signal. 16, 597–632.Keywords
This publication has 356 references indexed in Scilit:
- Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes onBiochemical Pharmacology, 2011
- One Enzyme, Two FunctionsJournal of Biological Chemistry, 2010
- A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activityAnalytical Biochemistry, 2010
- Activation of AMP-activated Protein Kinase Suppresses Oxidized Low-density Lipoprotein-induced Macrophage ProliferationJournal of Biological Chemistry, 2009
- Determinants of variation in human serum paraoxonase activityHeredity, 2008
- Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoningProceedings of the National Academy of Sciences of the United States of America, 2008
- Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular RiskJAMA, 2008
- Diabetes, oxidative stress, and antioxidants: A reviewJournal of Biochemical and Molecular Toxicology, 2003
- Inflammation in atherosclerosisNature, 2002
- Innate and acquired immunity in atherogenesisNature Medicine, 2002